Search - tctmd.com

Displaying 41 - 60 of 1782

Sort: Relevancy | Date

Presentation TCT 2016

Complications Related to Contrast and Commonly Used Medications

Presenter: Giora Weisz, Payam Dehghani

November 01, 2016

Presentation TCT 2016

Complications Encountered During and After ASD Closure

Presenter: Lee N. Benson, Ziyad M. Hijazi, Zahid Amin

November 01, 2016

News Conference News TCT 2016

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Yael L. Maxwell

November 01, 2016

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Shelley Wood

November 01, 2016

News Conference News TCT 2016

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Todd Neale

November 01, 2016

Presentation TCT 2016

Atherectomy in SFA CTOs: How to Maximize Outcomes and Prevent Complications

Presenter: Jihad A. Mustapha, Craig M. Walker, Roger Gammon

November 01, 2016

Presentation TCT 2016

Venezuela Presents: A Case of a TAVR Complication

Presenter: Juan F. Granada, Oscar A. Mendiz, Carlos D Calderas

November 01, 2016

Presentation TCT 2016

Argentina Presents: A Case of a TAVR Complication

Presenter: Juan F. Granada, Oscar A. Mendiz

November 01, 2016

Presentation TCT 2016

Saudi Arabia Presents: A Case of Coronary Compression After TAVR

Presenter: Juan F. Granada, Oscar A. Mendiz, Fawaz AlMotairi

November 01, 2016

Presentation TCT 2016

Saudi Arabia Presents: A Case When TAVR Crashes

Presenter: Juan F. Granada, Oscar A. Mendiz, Khaled F Al-Shaibi

November 01, 2016

Presentation TCT 2016

Complications 5. Bleeding after TAVR: Incidence, Prognostic Importance, Predictors, and Associations

Presenter: Neil E. Moat, John G. Webb, Philippe Généreux

October 31, 2016

Presentation TCT 2016

Strategies to Reduce the Frequency of New Pacemakers After TAVR: Imaging, Procedural, and Device-Related Factors

Presenter: Neil E. Moat, John G. Webb, Ian T. Meredith

October 31, 2016

Presentation TCT 2016

Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR

Presenter: Neil E. Moat, John G. Webb, Marina Urena

October 31, 2016

Presentation TCT 2016

Strokes and TAVR: Is Stroke Frequency Declining? Etiologic Factors Clinical, Anatomic, Technique-related, and Device-specific

Presenter: Neil E. Moat, John G. Webb, Samir R. Kapadia

October 31, 2016

Presentation TCT 2016

Complications 3. The Spectrum of Neurologic Events After TAVR: Insights From NeuroARC

Presenter: Neil E. Moat, John G. Webb, Alexandra J. Lansky

October 31, 2016

Presentation TCT 2016

The Landscape of Alternative Access Strategies for TAVR (Apical, Direct Aorta, Subclavian, Carotid, and Caval)

Presenter: Neil E. Moat, John G. Webb, Adam B. Greenbaum

October 31, 2016

Presentation TCT 2016

Complications 2. How to Prevent and Treat Transfemoral Access Site Complications

Presenter: Neil E. Moat, John G. Webb, Stephen R. Ramee

October 31, 2016

Presentation TCT 2016

Italy Presents: How I Managed This Case

Presenter: Ariel Finkelstein, Ugo Limbruno, Giovanni Esposito

October 31, 2016

Presentation TCT 2016

The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging

Presenter: Neil E. Moat, John G. Webb, Pieter R. Stella

October 31, 2016

Presentation TCT 2016

Italy Responds: How Would I Treat?

Presenter: Ariel Finkelstein, Ugo Limbruno

October 31, 2016

Advertisement

Complications Related to Contrast and Commonly Used Medications

Complications Encountered During and After ASD Closure

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Atherectomy in SFA CTOs: How to Maximize Outcomes and Prevent Complications

Venezuela Presents: A Case of a TAVR Complication

Argentina Presents: A Case of a TAVR Complication

Saudi Arabia Presents: A Case of Coronary Compression After TAVR

Saudi Arabia Presents: A Case When TAVR Crashes

Complications 5. Bleeding after TAVR: Incidence, Prognostic Importance, Predictors, and Associations

Strategies to Reduce the Frequency of New Pacemakers After TAVR: Imaging, Procedural, and Device-Related Factors

Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR

Strokes and TAVR: Is Stroke Frequency Declining? Etiologic Factors Clinical, Anatomic, Technique-related, and Device-specific

Complications 3. The Spectrum of Neurologic Events After TAVR: Insights From NeuroARC

The Landscape of Alternative Access Strategies for TAVR (Apical, Direct Aorta, Subclavian, Carotid, and Caval)

Complications 2. How to Prevent and Treat Transfemoral Access Site Complications

Italy Presents: How I Managed This Case

The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging

Italy Responds: How Would I Treat?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content